OCUGEN, INC. Capital Expenditures Incurred but Not yet Paid
OCUGEN, INC. (OCGN) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-06
- OCUGEN, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $0.00.
- OCUGEN, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-06-30 was $19.00K.
- OCUGEN, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- OCUGEN, INC. capital expenditures incurred but not yet paid for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- OCUGEN, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- OCUGEN, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $2.19M, a 140.29% increase from fiscal 2022.
- OCUGEN, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $911.00K, a 5593.75% increase from fiscal 2021.
- OCUGEN, INC. capital expenditures incurred but not yet paid for fiscal 2021 was $16.00K, a 92.52% decline from fiscal 2020.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month | Capital Expenditures Incurred but Not yet Paid 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $19.00K derived: sum of 2 quarters · filed 2026-08-06 | $19.00K 10-Q · filed 2025-11-05 | $19.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $19.00K 10-Q · filed 2026-08-06 | $19.00K derived: sum of 3 quarters · filed 2026-08-06 | -$227.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-05-09 | -$246.00K derived: sum of 3 quarters · filed 2025-11-05 | -$371.00K derived: sum of 4 quarters · filed 2025-11-05 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | -$246.00K derived: sum of 2 quarters · filed 2025-11-05 | -$371.00K derived: sum of 3 quarters · filed 2025-11-05 | $0.00 10-K · filed 2025-03-05 | |
| 2024-09-30 | -$246.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$371.00K derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $220.00K derived: sum of 4 quarters · filed 2025-11-05 | |
| 2024-06-30 | -$125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $246.00K 10-Q · filed 2025-08-04 | $466.00K derived: sum of 3 quarters · filed 2025-08-04 | -$202.00K derived: sum of 4 quarters · filed 2025-08-04 | |
| 2024-03-31 | $371.00K 10-Q · filed 2025-05-09 | $591.00K derived: sum of 2 quarters · filed 2025-05-09 | -$77.00K derived: sum of 3 quarters · filed 2025-05-09 | $1.44M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | $220.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | -$448.00K derived: sum of 2 quarters · filed 2025-03-05 | $1.07M derived: sum of 3 quarters · filed 2025-03-05 | $2.19M 10-K · filed 2025-03-05 | |
| 2023-09-30 | -$668.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $850.00K derived: sum of 2 quarters · filed 2024-11-14 | $1.97M 10-Q · filed 2024-11-14 | $1.65M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.64M 10-Q · filed 2024-08-08 | $2.32M derived: sum of 3 quarters · filed 2024-08-08 | $3.06M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $1.12M 10-Q · filed 2024-05-14 | $799.00K derived: sum of 2 quarters · filed 2024-05-14 | $1.54M derived: sum of 3 quarters · filed 2024-05-14 | $1.42M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | -$320.00K derived: 10-K 12 month − 10-K 9 month · filed 2024-04-16 | $420.00K derived: sum of 2 quarters · filed 2024-04-16 | $300.00K derived: sum of 3 quarters · filed 2024-04-16 | $911.00K 10-K · filed 2024-04-16 | |
| 2022-09-30 | $740.00K derived: 10-K 9 month − 10-K 6 month · filed 2024-04-16 | $620.00K derived: sum of 2 quarters · filed 2024-04-16 | $1.23M 10-K · filed 2024-04-16 | $1.24M derived: sum of 4 quarters · filed 2024-04-16 | |
| 2022-06-30 | -$120.00K derived: 10-K 6 month − 10-K 3 month · filed 2024-04-16 | $491.00K 10-K · filed 2024-04-16 | $498.00K derived: sum of 3 quarters · filed 2024-04-16 | $429.00K derived: sum of 4 quarters · filed 2024-04-16 | |
| 2022-03-31 | $611.00K 10-K · filed 2024-04-16 | $618.00K derived: sum of 2 quarters · filed 2024-04-16 | $549.00K derived: sum of 3 quarters · filed 2024-04-16 | $583.00K derived: sum of 4 quarters · filed 2024-04-16 | |
| 2021-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$62.00K derived: sum of 2 quarters · filed 2023-02-28 | -$28.00K derived: sum of 3 quarters · filed 2023-02-28 | $16.00K 10-K · filed 2023-02-28 | |
| 2021-09-30 | -$69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$35.00K derived: sum of 2 quarters · filed 2022-11-08 | $9.00K 10-Q · filed 2022-11-08 | $223.00K derived: sum of 4 quarters · filed 2022-11-08 | |
| 2021-06-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $78.00K 10-Q · filed 2022-08-05 | $292.00K derived: sum of 3 quarters · filed 2022-08-05 | $292.00K derived: sum of 4 quarters · filed 2022-08-05 | |
| 2021-03-31 | $44.00K 10-Q · filed 2022-05-06 | $258.00K derived: sum of 2 quarters · filed 2022-05-06 | $258.00K derived: sum of 3 quarters · filed 2022-05-06 | $258.00K derived: sum of 4 quarters · filed 2022-05-06 | |
| 2020-12-31 | $214.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $214.00K derived: sum of 2 quarters · filed 2022-02-28 | $214.00K derived: sum of 3 quarters · filed 2022-02-28 | $214.00K 10-K · filed 2022-02-28 | $213.63K 10-K · filed 2021-03-19 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $0.00 10-Q · filed 2021-08-06 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-07 | ||||
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 | ||||
| 2018-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$729.00K derived: sum of 2 quarters · filed 2019-03-22 | -$780.00K derived: sum of 3 quarters · filed 2019-08-09 | $125.00K 10-K · filed 2019-03-22 | |
| 2018-09-30 | -$801.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$852.00K derived: sum of 2 quarters · filed 2019-08-09 | $53.00K 10-Q · filed 2018-11-08 | ||
| 2018-06-30 | -$51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $854.00K 10-Q · filed 2019-08-09 | |||
| 2018-03-31 | $905.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |